HER2 status was associated with clinical variables and DFS in patients with stage II-III CRC according to the HERACLES criteria, yet, the results were not found according to the HER2 diagnostic criteria for gastroesophageal adenocarcinoma. Here, ERBB2 is linked to colorectal carcinoma.